These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2457160

  • 1. Drug discrimination in human post-addicts: agonist/antagonist opioids.
    Preston K, Bigelow G, Bickel W, Liebson I.
    NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160
    [No Abstract] [Full Text] [Related]

  • 2. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
    [Abstract] [Full Text] [Related]

  • 3. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [Abstract] [Full Text] [Related]

  • 4. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination.
    Preston KL, Liebson IA, Bigelow GE.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):62-71. PubMed ID: 1373189
    [Abstract] [Full Text] [Related]

  • 5. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE, Bigelow GE, Preston KL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [Abstract] [Full Text] [Related]

  • 6. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL, Bigelow GE, Bickel WK, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [Abstract] [Full Text] [Related]

  • 7. Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
    Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):47-53. PubMed ID: 2459370
    [Abstract] [Full Text] [Related]

  • 8. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
    Picker MJ.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
    [Abstract] [Full Text] [Related]

  • 9. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR.
    Contemp Anesth Pract; 1983 Mar; 7():27-43. PubMed ID: 6136392
    [No Abstract] [Full Text] [Related]

  • 10. Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.
    Strain EC, Walsh SL, Bigelow GE.
    Psychopharmacology (Berl); 2002 Jan; 159(2):161-6. PubMed ID: 11862344
    [Abstract] [Full Text] [Related]

  • 11. Assessment of buprenorphine in a drug discrimination procedure in humans.
    Bigelow GE, Preston KL.
    NIDA Res Monogr; 1992 Jan; 121():28-37. PubMed ID: 1406908
    [Abstract] [Full Text] [Related]

  • 12. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ, Cook CD.
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [Abstract] [Full Text] [Related]

  • 13. Properties of pentazocine as a discriminative stimulus in the squirrel monkey.
    White JM, Holtzman SG.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):396-401. PubMed ID: 7131294
    [Abstract] [Full Text] [Related]

  • 14. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
    Picker MJ, Yarbrough J, Hughes CE, Smith MA, Morgan D, Dykstra LA.
    J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
    [Abstract] [Full Text] [Related]

  • 15. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [Abstract] [Full Text] [Related]

  • 16. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
    Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE, Barta PE, Pearlson GD.
    Am J Psychiatry; 1998 Apr; 155(4):470-3. PubMed ID: 9545990
    [Abstract] [Full Text] [Related]

  • 17. Differential antagonism by naltrexone of the effects of opioids on a fixed-ratio discrimination in rats.
    Moerschbaecher JM, Devia C, Brocklehurst C.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):237-46. PubMed ID: 3336001
    [Abstract] [Full Text] [Related]

  • 18. Using agonist-antagonist opioids and antagonist drugs.
    Pasero C, McCaffery M.
    Am J Nurs; 1999 Jan; 99(1 Pt 1):20, 23. PubMed ID: 9932048
    [No Abstract] [Full Text] [Related]

  • 19. On the ability of narcotic antagonists to produce the narcotic cue.
    Colpaert FC, Niemegeers CJ, Janssen PA.
    J Pharmacol Exp Ther; 1976 Apr; 197(1):180-7. PubMed ID: 4610
    [Abstract] [Full Text] [Related]

  • 20. Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
    Young AM, Stephens KR, Hein DW, Woods JH.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):118-26. PubMed ID: 6142942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.